Contraception
Volume 76, Issue 2 , Pages 117-125 , August 2007

Safety, tolerance and acceptability of the Invisible Condom® and its vaginal applicator in healthy women and their male sexual partners

  • Sylvie Trottier

      Affiliations

    • Infectious Diseases Research Centre, Université Laval, Québec, QC, Canada G1V 4G2
    • Dr. Trottier and Dr. Omar are first co-authors.
    • ,
  • Rabeea F. Omar

      Affiliations

    • Infectious Diseases Research Centre, Université Laval, Québec, QC, Canada G1V 4G2
    • Dr. Trottier and Dr. Omar are first co-authors.
    • ,
  • André Désormeaux

      Affiliations

    • Infectious Diseases Research Centre, Université Laval, Québec, QC, Canada G1V 4G2
    • ,
  • Jean Drouin

      Affiliations

    • Family Planning Clinics, Centre Hospitalier Universitaire de Québec (Centre Hospitalier de l’Université Laval, G1V 4G2 and Saint-François d’Assise, G1L 3L5), Québec, QC, Canada
    • ,
  • Marie-Thérèse Gagnon

      Affiliations

    • Family Planning Clinics, Centre Hospitalier Universitaire de Québec (Centre Hospitalier de l’Université Laval, G1V 4G2 and Saint-François d’Assise, G1L 3L5), Québec, QC, Canada
    • ,
  • Francine Vezina

      Affiliations

    • Family Planning Clinics, Centre Hospitalier Universitaire de Québec (Centre Hospitalier de l’Université Laval, G1V 4G2 and Saint-François d’Assise, G1L 3L5), Québec, QC, Canada
    • ,
  • Edith Guilbert

      Affiliations

    • Family Planning Clinics, Centre Hospitalier Universitaire de Québec (Centre Hospitalier de l’Université Laval, G1V 4G2 and Saint-François d’Assise, G1L 3L5), Québec, QC, Canada
    • ,
  • Benoît Mâsse

      Affiliations

    • Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson, Cancer Research Center, Seattle, WA 98109-1024, USA
    • ,
  • Michel G. Bergeron

      Affiliations

    • Infectious Diseases Research Centre, Université Laval, Québec, QC, Canada G1V 4G2
    • Corresponding Author InformationCorresponding author. Infectious Diseases Research Centre, Université Laval, Centre Hospitalier de l'Université Laval (CHUL), CHUQ, Quebec, QC, Canada G1V 4G2. Tel.: +418 654 2705; fax: +418 654 2715.

Received 28 January 2007 ,Revised 2 April 2007 ,Accepted 26 April 2007.

References 

  1. WHO . The world health report 2002 — Reducing Risks, Promoting Healthy Life. http://www.who.int/whr/2002/en#2002;[Accessed 10/04]
  2. WHO . Global prevalence and incidence of selected curable sexually transmitted infections. Overview and estimates. Reference Number: WHO/HIV_AIDS/2001.02. http://www.who.int/hiv/pub/sti/pub7/en/index.html2001;
  3. Lee K. The toll of HIV/AIDS on minority women. In: HIV impact―a closing the gap newsletter of minority health, US Department of Health and Human Services. Spring 2000;p. 1–2
  4. Johnston R. Microbicides 2002: An update. AIDS Patient Care and STDs. 2002;16:419–430
  5. Piret J, Gagne N, Perron S, et al. Thermoreversible gel as a candidate barrier to prevent the transmission of HIV-1 and herpes simplex virus type 2. Sex Transm Dis. 2001;28:484–491
  6. Roy S, Gourde P, Piret J, et al. Thermoreversible gel formulations containing sodium lauryl sulfate or n-Lauroylsarcosine as potential topical microbicides against sexually transmitted diseases. Antimicrob Agents Chemother. 2001;45:1671–1681
  7. Gagne N, Cormier H, Omar RF, et al. Protective effect of a thermoreversible gel against the toxicity of nonoxynol-9. Sex Transm Dis. 1999;26(3):177–183
  8. Bestman-Smith J, Piret J, Desormeaux A, Tremblay MJ, Omar RF, Bergeron MG. Sodium lauryl sulfate abrogates human immunodeficiency virus infectivity by affecting viral attachment. Antimicrob Agents Chemother. 2001;45:2229–2237
  9. Piret J, Roy S, Gagnon M, et al. Comparative study of mechanisms of herpes simplex virus inactivation by sodium lauryl sulfate and n-lauroylsarcosine. Antimicrob Agents Chemother. 2002;46:2933–2942
  10. Howett MK, Neely EB, Christensen ND, et al. A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses. Antimicrob Agents Chemother. 1999;43:314–321
  11. Haineault C, Gourde P, Perron S, et al. Thermoreversible gel formulation containing sodium lauryl sulfate as a potential contraceptive device. Biol Reprod. 2003;59:687–694
  12. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosis bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol. 1991;29:297–301
  13. Renton KA, Kay GW, van der Walt LA. A simple assay for human sperm agglutination antibodies. Arch Androl. 1982;8:213–216
  14. Amsel R, Totten PA, Spiegel CA, Chen KCS, Eschenbach DA, Holmes KK. Non-specific vaginitis. Am J Med. 1983;74:12–22
  15. World Health Organization (WHO) Contraceptive Research and Development Program (CONRAD). Manual for the standardisation of colposcopy for the evaluation of vaginal products. Update 2004, manual WHO/RHR/04.2; CONRAD/2004.1.
  16. Tabbara S, Saleh AM, Anderson WA, et al. The Bethesda classification for squamous intraepithelial lesions: histologic, cytologic and viral correlates. Obstet Gynecol. 1992;79:338–346
  17. Eschenbach DA, Patton DL, Meier A, Thwin SS, et al. Effects of oral contraceptive pill use on vaginal flora and vaginal epithelium. Contraception. 2000;62:107–112
  18. Gupta K, Hillier S, Hooton T, Roberts P, Stomn W. Effects of contraceptive method on the vaginal microflora: a perspective evaluation. J Infect Dis. 2000;181:595–601
  19. Mostad SB, Overbaugh J, DeVange DM, et al. Hormonal contraception, vitamin A deficiency and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet. 1997;350:922–927
  20. Gupta KM, Barnes SR, Tangaro RA, et al. Temperature and pH sensitive smart hydrogels: an approach towards smart semen-triggered vaginal microbicidal vehicles. J Pharmaceutical Sci. 2007;96(3):670–681
  21. Juhasz J, Pimienta C, Lenaerts V. Adhesion of poloxamer 407 formulations on dog ileal segments in vitro. Eur J Pharm Biopharm. 1991;37:262–265
  22. El-Sadr WM, Mayer KH, Maslankowski L, Hoesley C, Justman J, Gai F, et al. Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women. AIDS. 2006;20:1109–1116
  23. Mayer KH, Maslanowski L, Gai F, et al. HPTN 050 Protocol Team. Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women. AIDS. 2006;20:543–551
  24. Lacey CJN, Mayer KH, Abdool S, et al. Safety and tolerance of PRO 2000 gel, a candidate vaginal microbicide, in different populations. In: XIV International AIDS Conference; Barcelona; Spain, July 7–12. 2002;[Abstract MoPeD3652]
  25. Mayer K, Peipert J, Fleming T, et al. Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States. Clin Infect Dis. 2001;32:476–482
  26. Coetzee N, Hoosen A, Blanchard K, et al. A randomized, placebo-controlled, double-blind expanded safety trial of Carraguard microbicide gel in South Africa: signs and symptoms of genital irritation. In: XIV International AIDS Conference, Barcelona, Spain. 2002;[Abstract: WeOrD1316]
  27. Joshi S, Dutta S, Bell B, Profy A, Kuruc J, Gai F, et al. HIV Prevention Trial Network (HPTN) 047 Protocol Team. Phase I safety study of 0.5% PRO 2000 vaginal Gel among HIV un-infected women in Pune India. AIDS Res Ther. 2006;3:4
  28. Trottier S, Omar RF, Désormeaux A, et al. Phase I clinical trial to evaluate the safety, tolerance and acceptability of the Invisible Condom when applied intravaginally to healthy female subjects. In: XIV International AIDS Conference, Barcelona, Spain. 2002;[Abstract: LbPp2212]
  29. Bergeron MG, Omar RF, Désormeaux A, Gagnon MT, Vezina F, Trottier S. Phase I clinical trial to evaluate the safety and acceptability of the Invisible Condom when applied intravaginally to healthy female subjects. “Microbicides 2002” meeting. Antwerp, Belgium. 2002;[Abstract: B-151]

☆ This work was financially supported by a joint grant from the Canadian International Development Agency (CIDA) and Health Canada.

PII: S0010-7824(07)00197-7

doi: 10.1016/j.contraception.2007.04.015

Contraception
Volume 76, Issue 2 , Pages 117-125 , August 2007

Article Tools

* Image Usage & Resolution